Literature DB >> 15019208

Antimicrobial polypeptides of the human colonic epithelium.

Scott J Howell1, Dennis Wilk, Satya P Yadav, Charles L Bevins.   

Abstract

The lumen of the human colon is heavily colonized with microbes, but infections across its epithelial surface are infrequent. To address the hypothesis that antimicrobial polypeptides contribute to the barrier function of colonic epithelial cells, we examined cellular extracts from non-inflamed colonic mucosa using an antimicrobial assay. This approach yielded five polypeptides: three antimicrobials were previously identified as ribosomal polypeptides (L30, S19 and ubiquicidin), and two were members of the histone family (H1.5 and H2B). All exhibited bactericidal activity against Escherichia coli, and with the exception of S19, had been isolated by others based on their potent antimicrobial activity in other cells and tissues. These polypeptides normally reside inside cells and are proposed to contribute to the formation of the functional antimicrobial barrier of the colonic epithelium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15019208     DOI: 10.1016/j.peptides.2003.07.028

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  17 in total

1.  Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes.

Authors:  Yingwei Wang; Yang Chen; Lijun Xin; Stephen M Beverley; Eric D Carlsen; Vsevolod Popov; Kwang-Poo Chang; Ming Wang; Lynn Soong
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

Review 2.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 3.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

4.  Analysis of the Staphylococcus aureus abscess proteome identifies antimicrobial host proteins and bacterial stress responses at the host-pathogen interface.

Authors:  Ahmed S Attia; James E Cassat; Sheg O Aranmolate; Lisa J Zimmerman; Kelli L Boyd; Eric P Skaar
Journal:  Pathog Dis       Date:  2013-10-01       Impact factor: 3.166

5.  Bacteroides fragilis enterotoxin induces human beta-defensin-2 expression in intestinal epithelial cells via a mitogen-activated protein kinase/I kappaB kinase/NF-kappaB-dependent pathway.

Authors:  Young Mee Yoon; Jin Young Lee; Doyoung Yoo; Young-Suk Sim; Young-Jeon Kim; Yu-Kyoung Oh; Ju Seop Kang; Sunil Kim; Joo Sung Kim; Jung Mogg Kim
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

Review 6.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

7.  Reduced mucosal antimicrobial activity in Crohn's disease of the colon.

Authors:  Sabine Nuding; Klaus Fellermann; Jan Wehkamp; Eduard F Stange
Journal:  Gut       Date:  2007-04-24       Impact factor: 23.059

Review 8.  Autophagy at the gut interface: mucosal responses to stress and the consequences for inflammatory bowel diseases.

Authors:  Alan Huett; Ramnik J Xavier
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

9.  Histone H4 is a major component of the antimicrobial action of human sebocytes.

Authors:  Dong-Youn Lee; Chun-Ming Huang; Teruaki Nakatsuji; Diane Thiboutot; Sun-Ah Kang; Marc Monestier; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2009-06-18       Impact factor: 8.551

10.  Antimicrobial activity of high-mobility-group box 2: a new function to a well-known protein.

Authors:  Robert Küchler; Bjoern O Schroeder; Simon U Jaeger; Eduard F Stange; Jan Wehkamp
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.